TapewireFind a company

person · Reporting owner

Kennedy Thomas Ronan

Disclosed activity across 1 company

Tapewire entity
72355
SEC CIK
0001826452

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
cbdMD, Inc.YCBD · Entity 8230Director · CEO and CFONovember 28, 2025December 02, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

cbdMD, Inc.

Report date November 28, 2025 · Filed December 02, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect513,722 Reported balance After 2025-11-28 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2025-11-28 · Grant · Acquired 445,000 · Balance 513,722

F1: The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval.

F2: The amount beneficially owned will not reconcile to the prior Form 4 due to a scriveners error.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval.

F2: The amount beneficially owned will not reconcile to the prior Form 4 due to a scriveners error.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 28, 2025 Filed Dec 2, 2025 23:29 UTC cbdMD, Inc. YCBD · Entity 8230 GrantCommon Stock 445,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-25-036688 · rdgdoc.xml · nonDerivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · Director · CEO and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 513,722

F1 · security: The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval.

F1 · price: The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval.

F2 · balance_after: The amount beneficially owned will not reconcile to the prior Form 4 due to a scriveners error.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:13 UTC cbdMD, Inc. YCBD · Entity 8230 Conversion8% Series A Cumulative Convertible Preferred Stock · Derivative 41,765 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-25-015501 · rdgdoc.xml · derivative · entry 2

Kennedy Thomas Ronan · CIK 0001826452 · Director · CEO and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 67,869 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time.

F2 · derivative.exercise_price: The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time.

F3 · price: Open market purchases.

F1 · derivative.exercise_date: The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time.

F1 · derivative.expiration_date: The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:13 UTC cbdMD, Inc. YCBD · Entity 8230 ConversionCommon Stock 67,869 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-25-015501 · rdgdoc.xml · nonDerivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · Director · CEO and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time.

F2 · price: The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time.

Read SEC document
September 26, 2024 Filed Sep 30, 2024 15:17 UTC cbdMD, Inc. YCBD · Entity 8230 Purchase8% Series A Cumulative Convertible Preferred Stock · Derivative 1,000 $0.55 Strike: $270.00 $550.00
Disclosure

SEC source: 0001437749-24-030227 · rdgdoc.xml · derivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · CEO and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By CRED Trust

Disclosed balance after: 41,765

Underlying: Common Stock · 4 shares

Expires not disclosed

F1 · derivative.exercise_date: The Preferred Stock has no maturity and remains outstanding unless a holder chooses to convert it into common stock, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the Preferred Stock filed on October 11, 2019 (the "Designation"), the Issuer elects to redeem it, or a Change of Control, occurs resulting in a mandatory redemption. The Issuer may elect to convert the Preferred Stock into shares of common stock if the closing price of the common stock has exceeded $371.25 for at least 20 out of 30 consecutive trading days ending within 5 trading days prior to the notice of automatic conversion. The Issuer may redeem the Preferred Stock at $10 per share, plus all accrued and unpaid dividends. Upon the occurrence of a Change of Control the Issuer will redeem all of the shares of Preferred Stock at $11 per share, plus any accrued but unpaid dividends.

F1 · derivative.expiration_date: The Preferred Stock has no maturity and remains outstanding unless a holder chooses to convert it into common stock, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the Preferred Stock filed on October 11, 2019 (the "Designation"), the Issuer elects to redeem it, or a Change of Control, occurs resulting in a mandatory redemption. The Issuer may elect to convert the Preferred Stock into shares of common stock if the closing price of the common stock has exceeded $371.25 for at least 20 out of 30 consecutive trading days ending within 5 trading days prior to the notice of automatic conversion. The Issuer may redeem the Preferred Stock at $10 per share, plus all accrued and unpaid dividends. Upon the occurrence of a Change of Control the Issuer will redeem all of the shares of Preferred Stock at $11 per share, plus any accrued but unpaid dividends.

F2 · ownership.nature: Represents shares of common stock held by CRED Trust for which the Reporting Person is the trustee and holds voting and dispositive control.

Read SEC document
September 23, 2024 Filed Sep 26, 2024 00:28 UTC cbdMD, Inc. YCBD · Entity 8230 Purchase8% Series A Cumulative Convertible Preferred Stock · Derivative 38,465 $0.60 Strike: $270.00 $23,052.07
Disclosure

SEC source: 0001437749-24-030008 · rdgdoc.xml · derivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · CEO and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By CRED Trust

Disclosed balance after: 40,765

Underlying: Common Stock · 143 shares

Expires not disclosed

F1 · derivative.exercise_date: The Preferred Stock has no maturity and remains outstanding unless a holder chooses to convert it into common stock, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the Preferred Stock filed on October 11, 2019 (the "Designation"), the Issuer elects to redeem it, or a Change of Control, occurs resulting in a mandatory redemption. The Issuer may elect to convert the Preferred Stock into shares of common stock if the closing price of the common stock has exceeded $371.25 for at least 20 out of 30 consecutive trading days ending within 5 trading days prior to the notice of automatic conversion. The Issuer may redeem the Preferred Stock at $10 per share, plus all accrued and unpaid dividends. Upon the occurrence of a Change of Control the Issuer will redeem all of the shares of Preferred Stock at $11 per share, plus any accrued but unpaid dividends.

F1 · derivative.expiration_date: The Preferred Stock has no maturity and remains outstanding unless a holder chooses to convert it into common stock, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the Preferred Stock filed on October 11, 2019 (the "Designation"), the Issuer elects to redeem it, or a Change of Control, occurs resulting in a mandatory redemption. The Issuer may elect to convert the Preferred Stock into shares of common stock if the closing price of the common stock has exceeded $371.25 for at least 20 out of 30 consecutive trading days ending within 5 trading days prior to the notice of automatic conversion. The Issuer may redeem the Preferred Stock at $10 per share, plus all accrued and unpaid dividends. Upon the occurrence of a Change of Control the Issuer will redeem all of the shares of Preferred Stock at $11 per share, plus any accrued but unpaid dividends.

F2 · ownership.nature: Represents shares of common stock held by CRED Trust for which the Reporting Person is the trustee and holds voting and dispositive control.

Read SEC document
May 03, 2023 Filed May 5, 2023 19:31 UTC cbdMD, Inc. YCBD · Entity 8230 PurchaseCommon Stock 5,000 $2.10 $10,500.00
Disclosure

SEC source: 0001437749-23-012787 · rdgdoc.xml · nonDerivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · Interim CEO and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,462

F1 · shares: The Reporting Person purchased $10,500 worth of common stock under an Issuer registered public offering of its common stock.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 18:09 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock Options · Derivative 75,000 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001654954-21-010812 · section16.xml · derivative · entry 4

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2026-10-01

F5 · security: The stock options were granted under the 2015 Equity Compensation Plan pursuant to the terms of the Executive Employment Agreement dated October 1, 2021, by and between the Issuer and the Reporting Person. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options vest on October 1, 2022, subject to continued employment on the applicable vesting date.

F6 · price: Not applicable.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 18:09 UTC cbdMD, Inc. YCBD · Entity 8230 Exercise / conversionRestricted Stock Unites · Derivative 16,667 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-010812 · section16.xml · derivative · entry 3

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units were granted on October 1, 2021 and vest on October 1, 2022.

F4 · derivative.expiration_date: The restricted stock units were granted on October 1, 2021 and vest on October 1, 2022.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 18:09 UTC cbdMD, Inc. YCBD · Entity 8230 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-010812 · section16.xml · nonDerivative · entry 2

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,067

F2 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units shall vest on January 1, 2022. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2015 Equity Compensation Plan pursuant to the terms of the Executive Employment Agreement dated October 1, 2021, by and between the Issuer and the Reporting Person.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 18:09 UTC cbdMD, Inc. YCBD · Entity 8230 Exercise / conversionCommon Stock 16,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001654954-21-010812 · section16.xml · nonDerivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares of common stock to be issued upon the vesting of restricted stock units which vest on October 1, 2021.

Read SEC document
August 24, 2021 Filed Aug 25, 2021 14:15 UTC cbdMD, Inc. YCBD · Entity 8230 Purchase8% Series A Cumulative Convertible Preferred Stock · Derivative 2,300 $6.52 Strike: $6.00 $15,005.20
Disclosure

SEC source: 0001654954-21-009413 · section16.xml · derivative · entry 2

Kennedy Thomas Ronan · CIK 0001826452 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,300

Underlying: Common Stock · 3,834 shares

Expires not disclosed

F1 · derivative.exercise_date: The Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") has no stated maturity and will remain outstanding indefinitely unless a holder chooses to convert the Preferred Stock into shares of the Issuer's common stock at any time, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the 8% Series A Cumulative Convertible Preferred Stock filed on October 11, 2019 (the "Designation"), on or after October 16, 2023 the Issuer elects to redeem it, or a Change of Control, (as defined in the Designation) occurs resulting in a mandatory redemption. The Issuer may elect to automatically convert some or all of the Preferred Stock into shares of its common stock if the closing price of the common stock has exceeded $8.25 (137.5% of the Conversion Price) for at least 20 out of 30 consecutive trading days ending within five trading days prior to the notice of automatic conversion. The Preferred Stock will not be redeemable before October 16, 2023 except as described below upon the occurrence of a Change of Control. Commencing on October 16, 2023, the Issuer may redeem, at its option, the Preferred Stock, in whole or in part, at a cash redemption price of $10.00 per share, plus all accrued and unpaid dividends to, but not including, the redemption date. Upon the occurrence of a Change of Control the Issuer is required to redeem any or all of the shares of Series A Convertible Preferred Stock at a redemption price of $11.00 per share, plus any accrued but unpaid dividends to, but excluding, the redemption date.

F1 · derivative.expiration_date: The Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") has no stated maturity and will remain outstanding indefinitely unless a holder chooses to convert the Preferred Stock into shares of the Issuer's common stock at any time, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the 8% Series A Cumulative Convertible Preferred Stock filed on October 11, 2019 (the "Designation"), on or after October 16, 2023 the Issuer elects to redeem it, or a Change of Control, (as defined in the Designation) occurs resulting in a mandatory redemption. The Issuer may elect to automatically convert some or all of the Preferred Stock into shares of its common stock if the closing price of the common stock has exceeded $8.25 (137.5% of the Conversion Price) for at least 20 out of 30 consecutive trading days ending within five trading days prior to the notice of automatic conversion. The Preferred Stock will not be redeemable before October 16, 2023 except as described below upon the occurrence of a Change of Control. Commencing on October 16, 2023, the Issuer may redeem, at its option, the Preferred Stock, in whole or in part, at a cash redemption price of $10.00 per share, plus all accrued and unpaid dividends to, but not including, the redemption date. Upon the occurrence of a Change of Control the Issuer is required to redeem any or all of the shares of Series A Convertible Preferred Stock at a redemption price of $11.00 per share, plus any accrued but unpaid dividends to, but excluding, the redemption date.

Read SEC document
August 24, 2021 Filed Aug 25, 2021 14:15 UTC cbdMD, Inc. YCBD · Entity 8230 PurchaseCommon stock 7,400 $2.04 $15,096.00
Disclosure

SEC source: 0001654954-21-009413 · section16.xml · nonDerivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,400

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 41,666 $0.00 Strike: $6.50 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 12

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,666

Underlying: Common stock · 41,666 shares

Expires 2028-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 41,667 $0.00 Strike: $6.50 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 11

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common stock · 41,667 shares

Expires 2027-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 41,667 $0.00 Strike: $6.50 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 10

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common stock · 41,667 shares

Expires 2026-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 41,666 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 9

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,666

Underlying: Common stock · 41,666 shares

Expires 2028-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 41,667 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 8

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common stock · 41,667 shares

Expires 2027-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 41,667 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 7

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common stock · 41,667 shares

Expires 2026-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 33,333 $0.00 Strike: $3.50 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 6

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common stock · 33,333 shares

Expires 2028-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 33,333 $0.00 Strike: $3.50 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 5

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common stock · 33,333 shares

Expires 2027-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantStock option · Derivative 33,334 $0.00 Strike: $3.50 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 4

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,334

Underlying: Common stock · 33,334 shares

Expires 2026-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantRestricted stock award · Derivative 16,666 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 3

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common stock · 16,666 shares

Expires 2023-10-01

F3 · security: RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2023 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantRestricted stock award · Derivative 16,667 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 2

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common stock · 16,667 shares

Expires 2022-10-01

F2 · security: RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2022 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document
October 01, 2020 Filed Oct 1, 2020 21:02 UTC cbdMD, Inc. YCBD · Entity 8230 GrantRestricted stock award · Derivative 16,667 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common stock · 16,667 shares

Expires 2021-10-01

F1 · security: Restricted stock award ("RSA") granted under the Issuer's 2015 Equity Compensation Plan (the "Plan") pursuant to the terms of the Executive Employment Agreement dated September 15, 2020, with an effective date of October 1, 2020 (the "Employment Agreement") by and between the Issuer and the Reporting Person. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2021 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.